Your browser doesn't support javascript.
loading
Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes.
Koska, Juraj; Yassine, Hussein; Trenchevska, Olgica; Sinari, Shripad; Schwenke, Dawn C; Yen, Frances T; Billheimer, Dean; Nelson, Randall W; Nedelkov, Dobrin; Reaven, Peter D.
Affiliation
  • Koska J; Phoenix Veterans Affairs Health Care System, Phoenix, AZ juraj.koska@va.gov.
  • Yassine H; University of Southern California, Los Angeles, CA.
  • Trenchevska O; Arizona State University, Tempe, AZ.
  • Sinari S; University of Arizona, Tucson, AZ.
  • Schwenke DC; Phoenix Veterans Affairs Health Care System, Phoenix, AZ.
  • Yen FT; Université de Lorraine, URAFPA, INSERM, Vandoeuvre-lès-Nancy, France.
  • Billheimer D; University of Arizona, Tucson, AZ.
  • Nelson RW; Arizona State University, Tempe, AZ.
  • Nedelkov D; Arizona State University, Tempe, AZ.
  • Reaven PD; Phoenix Veterans Affairs Health Care System, Phoenix, AZ.
J Lipid Res ; 57(5): 894-905, 2016 05.
Article in En | MEDLINE | ID: mdl-26945091

Full text: 1 Database: MEDLINE Main subject: Prediabetic State / Diabetes Mellitus, Type 2 / Apolipoprotein C-III Type of study: Clinical_trials / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Lipid Res Year: 2016 Type: Article Affiliation country: Azerbaijan

Full text: 1 Database: MEDLINE Main subject: Prediabetic State / Diabetes Mellitus, Type 2 / Apolipoprotein C-III Type of study: Clinical_trials / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Lipid Res Year: 2016 Type: Article Affiliation country: Azerbaijan